Skip to main content
. 2015 May 5;2(2):153–161. doi: 10.1007/s40801-015-0024-7

Table 2.

Percentage change in age-specific invasive pneumococcal disease (IPD) incidence (2000 versus 2008)

PCV7 (%) PCV7SR (%) All (%) All less epidemic (%)
Including PCV7 and epidemic Excluding PCV7
Age group
 <2 years −98 119 −70 154 −71
 2–4 years −86 527 −57 198 −57
 5–9 years −42 0 1 154 30
 10–14 years −100 0 0 201 −33
 15–19 years −70 0 −55 −10 −55
 20–64 years −53 322 48 134 29
 65+ years −83 168 −7 98 −12
Total −76 246 3 134 −9

PCV7 7-valent pneumococcal conjugate vaccine, PCV7SR PCV7-related serotype replacement